In Vitro Metabolism of 1‐Benzoyl‐Lysergic Acid Diethylamide (1Bz‐LSD) and Identification of a Deethylated Metabolite (1Bz‐LAE) Using a Synthesized Reference Standard
Drug Testing and Analysis · 2026
DOI: 10.1002/dta.70042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Testing and Analysis, 2026. Verfasst von Yuki Azuma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hygienic Chemistry, Osaka Institute of Public Health, Osaka, Japan. Hauptthemen laut MEDLINE: Lysergic Acid Diethylamide, Hallucinogens. Die Arbeit nennt 30 Literaturangaben. Gefördert von: JSPS KAKENHI.
Abstract (Originalsprache)
Lysergic acid diethylamide (LSD) analogs represent an emerging class of new psychoactive substances (NPS). These compounds are often rapidly metabolized, making direct detection of the parent compound in biological samples difficult. Therefore, metabolite detection serves as a critical and effective strategy for the confirmation of consumption. However, the metabolic pathways of these analogs remain largely uncharacterized, and synthesized metabolite standards for definitive identification are mostly unavailable. This study investigated the newly emerged LSD analog, (8 R )‐1‐benzoyl‐ N,N ‐diethyl‐6‐methyl‐9,10‐didehydroergoline‐8‐carboxamide (1‐benzoyl‐LSD, 1Bz‐LSD), which features a benzoyl moiety at the N 1 position. The objectives were to characterize its metabolic fate and synthesize a targeted metabolite analyte for the confirmation of consumption. In vitro metabolism of 1Bz‐LSD was examined using human liver microsomes and analyzed through liquid chromatography–quadrupole time‐of‐flight mass spectrometry. The parent compound was rapidly metabolized, yielding 15 metabolites, including LSD. Among these, a deethylated metabolite was detectable over a prolonged period, indicating its potential as a targeted analyte. To confirm its structure, this metabolite was chemically synthesized and identified as 1‐benzoyl‐lysergic acid ethylamide (1Bz‐LAE). The synthesis and identification of 1Bz‐LAE provide a crucial analytical foundation for the investigations of 1Bz‐LSD use, with this metabolite anticipated to function as a valuable marker.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hygienic Chemistry, Osaka Institute of Public Health, Osaka, Japan.
ORCID-Profile: Yuki Azuma, Akiko Asada, Misa Tanaka, Takahiro Doi
Förderung
- JSPS KAKENHI
Zitieren
APA
Azuma, Y., Asada, A., Tanaka, M., & Doi, T. (2026). In Vitro Metabolism of 1‐Benzoyl‐Lysergic Acid Diethylamide (1Bz‐LSD) and Identification of a Deethylated Metabolite (1Bz‐LAE) Using a Synthesized Reference Standard. Drug Testing and Analysis. https://doi.org/10.1002/dta.70042
Vancouver
Azuma Y, Asada A, Tanaka M, Doi T. In Vitro Metabolism of 1‐Benzoyl‐Lysergic Acid Diethylamide (1Bz‐LSD) and Identification of a Deethylated Metabolite (1Bz‐LAE) Using a Synthesized Reference Standard. Drug Testing and Analysis. 2026. doi:10.1002/dta.70042
BibTeX
@article{Azuma2026,
author = {Azuma, Yuki and Asada, Akiko and Tanaka, Misa and Doi, Takahiro},
title = {In Vitro Metabolism of 1‐Benzoyl‐Lysergic Acid Diethylamide (1Bz‐LSD) and Identification of a Deethylated Metabolite (1Bz‐LAE) Using a Synthesized Reference Standard},
journal = {Drug Testing and Analysis},
year = {2026},
doi = {10.1002/dta.70042}
}
EUVIMED